Clackson, Tim
Xilio Therapeutics,
United States
2024 Rank: 198796
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biotechnology
Rank in SubField 1: 6611 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 198796 | 222436 |
| Total Cites | 538 | 559 |
| H-index | 13 | 13 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 64 | 64 |
| Number of Single+First+Last Authored Papers | 28 | 28 |
| Total Cites to Single+First+Last Authored Papers | 148 | 148 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 426 | 441 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.27 |
| Self-Citation Percentage |
3.76%
|
|
Clackson, Tim
Takeda Pharmaceutical Company Limited,
United States
2023 Rank: 105454
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biotechnology
Rank in SubField 1: 3767 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 105454 | 122501 |
| Total Cites | 660 | 692 |
| H-index | 15 | 15 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 76 | 76 |
| Number of Single+First+Last Authored Papers | 27 | 27 |
| Total Cites to Single+First+Last Authored Papers | 187 | 189 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 493 | 512 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.35 |
| Self-Citation Percentage |
4.62%
|
|
Clackson, Tim
ARIAD Pharmaceuticals, Inc.,
United States
2022 Rank: 139369
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biotechnology
Rank in SubField 1: 5246 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 139369 | 152851 |
| Total Cites | 631 | 690 |
| H-index | 14 | 15 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 95 | 95 |
| Number of Single+First+Last Authored Papers | 27 | 27 |
| Total Cites to Single+First+Last Authored Papers | 196 | 203 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 484 | 520 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.33 |
| Self-Citation Percentage |
8.55%
|
|
Clackson, Tim
ARIAD Pharmaceuticals, Inc.,
United States
2021 Rank: 130793
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biotechnology
Rank in SubField 1: 4673 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 130793 | 145906 |
| Total Cites | 954 | 1041 |
| H-index | 16 | 17 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 145 | 145 |
| Number of Single+First+Last Authored Papers | 27 | 27 |
| Total Cites to Single+First+Last Authored Papers | 284 | 291 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 734 | 787 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.32 |
| Self-Citation Percentage |
8.36%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.